Results 121 to 130 of about 10,365,683 (253)

Therapies for Cardiovascular‐Kidney‐Liver‐Metabolic Syndrome: Reappraisal of Fibrates

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Cardiovascular disease, chronic kidney disease (CKD), type 2 diabetes mellitus (T2DM), obesity and metabolic dysfunction‐associated steatohepatitis (MASH) frequently coexist and share overlapping pathophysiology, forming the proposed cardiovascular‐kidney‐liver‐metabolic (CKLM) syndrome.
Virginia Anagnostopoulou, Christoforos K. Travlos, Lucas Lage Marinho, Thomas A. Mavrakanas, João Pedro Ferreira, Abhinav Sharma   +5 more
wiley   +1 more source

Omnipod 5 Delivers Superior Economic Value Compared to Multiple Daily Injections: A Cost‐Effectiveness Analysis in Adults With T1D From a Payer Perspective in Sweden

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aim Analyse the cost‐effectiveness of the Omnipod 5 automated insulin delivery system versus multiple daily injections (MDI) with continuous glucose monitoring for type 1 diabetes among adults in Sweden. Methods Cost‐effectiveness was analysed with the IQVIA Core Diabetes Model (version 10.0) taking the perspective of the payer in Sweden ...
Johan Jendle, Colin Hopley, Anuj Narang, Raffaele Scarica, Helena Hellerstedt, Melanie Littlewood   +5 more
wiley   +1 more source

Ten‐Year Cost‐Effectiveness of the Risk Assessment and Management Programme—Diabetes Mellitus (RAMP‐DM) Relative to Usual Care in Hong Kong Public Primary Care: A Population‐Based Cohort Study

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims The Risk Assessment and Management Programme—Diabetes Mellitus (RAMP‐DM) is a multidisciplinary, protocol‐driven, risk‐stratified care model integrated into public primary care in Hong Kong for patients with type 2 diabetes mellitus (T2DM).
Eric Ho Man Tang, Ivy Lynn Mak, Emily Tsui Yee Tse, Esther Yee Tak Yu, Julie Yun Chen, Weng Yee Chin, David Vai Kiong Chao, Wendy Wing Sze Tsui, Tony King Hang Ha, Carlos King Ho Wong, Cindy Lo Kuen Lam, Eric Yuk Fai Wan   +11 more
wiley   +1 more source

Non-Proliferative Diabetic Retinopathy [PDF]

, 2020
openaire   +1 more source

Clinical outcomes of ranibizumab treatment in diabetic eye disease [PDF]

, 2015
Background: The vascular endothelial growth factor (VEGF) inhibitor ranibizumab is emerging as an efficacious treatment for diabetic macular oedema. Large clinical trials have shown improvements in visual acuity and reduced central retinal thickness ...
Comyn, OJ
core  

Longitudinal Metabolic Risk Factors Are Associated With Microvascular Complications

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Objective Determine associations between summaries of longitudinal metabolic risk factors and microvascular complications. Methods We performed a secondary analysis of participants with and without diabetes enrolled within the Atherosclerosis Risk in Communities Study that completed metabolic risk factors assessments four times across 11 years.
Cody H. Makinson, Jihyun Park, Eva L. Feldman, Brian C. Callaghan, Evan L. Reynolds   +4 more
wiley   +1 more source

Different Mechanisms Causing Macular Hole Development in Proliferative Diabetic Retinopathy

, 2012
Macular hole can be defined as the retinal defect involving the foveal region. Anatomically, it may be lamellar or full thickness. Other than senile idiopathic cases, trauma, high myopia and retinal detachment may be among the etiological factors ...
Sinan Tatlıpınar
core   +1 more source

Effectiveness of Adding GLP‐1 Receptor Agonists to SGLT2 Inhibitor Therapy in Chronic Kidney Disease: A Population Based Study

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Background Individually, sodium–glucose co‐transporter‐2 inhibitors (SGLT2i) and glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) have been shown to reduce major kidney and cardiovascular events in patients with chronic kidney disease (CKD). However, evidence supporting combined GLP‐1RA and SGLT2i therapy in this population remains limited.
Hussain Salim, Shaheer Qureshi, Gaurav S. Gulsin, Habib R. Khan, Saad Ahmed Waqas, Gerry P. McCann, Amit Garg, Mohammed Shurrab, Kamlesh Khunti, Muhammad Rashid   +9 more
wiley   +1 more source

Prevalence of Chronic Complications After Inaugural Admission in Intensive Care Unit for Type 1 Diabetes in the SFDT1 Cohort: The INAUGURAL Study

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Inaugural presentation at type 1 diabetes onset, as ketoacidosis, has been associated with poorer glycaemic control, but its relationship to diabetes‐related complications remains unclear. We assessed the association between inaugural intensive care unit (ICU) admission and long‐term diabetes‐related outcomes in adults.
Emmanuel Cosson, Gloria Aguayo, Amandine Créquer‐Grandhomme, Amar Bahloul, Eric Renard, Louis Potier, Pauline Schaepelynck, Agnès Sola‐Gazagnes, Anne Spiteri, Jean‐Pierre Riveline, Guy Fagherazzi   +10 more
wiley   +1 more source

Targeting pericyte retention in Diabetic Retinopathy: a review

Annals of Medicine
Diabetic retinopathy is a common yet severe complication of diabetes mellitus and is the leading cause of blindness in middle-aged adults. After years of poorly managed hyperglycemia, complications begin as non-proliferative diabetic retinopathy but can ...
Forrest Bohler, Lily Bohler, Varna Taranikanti   +2 more
doaj   +1 more source